Karsten Bahlmann

Karsten Bahlmann, PhD, MBA, is the Chief Scientific Officer at Abberior Instruments GmbH since 2016, bringing extensive experience in scientific research and innovation management. Previously, Karsten served as Innovator in Residence at Siemens Healthcare, where contributions included developing the Digital Health portfolio for Siemens Technology to Business unit. Educational credentials include an MBA from the MIT Sloan School of Management, a PhD in Physics/Biophysics from the Max Planck Institute for Biophysical Chemistry, and an M.S. in Physics from Heidelberg University. As a co-founder and CSO of TissueVision, Karsten helped advance photonics-based pre-clinical tissue imaging platforms, significantly impacting drug development and academic research. Early career experience includes a postdoctoral associate position at the Massachusetts Institute of Technology.